In a recent clinical update on the widely respected "This Week in Virology" (TWiV) podcast, Dr. Daniel Griffin and host…
Read More

In a recent clinical update on the widely respected "This Week in Virology" (TWiV) podcast, Dr. Daniel Griffin and host…
Read More
In a recent clinical update, Dr. Daniel Griffin and Vincent Racaniello of This Week in Virology (TWiV) expressed profound bewilderment…
Read More
On March 29, Insilico Medicine, a pioneer in artificial intelligence (AI)-driven drug discovery and development, announced a landmark collaboration with…
Read More
The global fight against tuberculosis (TB), a persistent and devastating infectious disease, has reached a critical juncture with the World…
Read More
The top executive of the largest public hospital system in New York City has ignited a significant debate within the…
Read More
In a recent episode of "This Week in Virology" (TWiV) podcast, episode 1290, Dr. Daniel Griffin provided his weekly clinical…
Read More
The pharmaceutical industry, perpetually grappling with the escalating costs and protracted timelines of drug development, is witnessing a significant paradigm…
Read More
The persistent and growing global challenge of neurodegenerative diseases, particularly Alzheimer’s disease, has intensified the search for modifiable risk factors…
Read More
A newly published multicenter clinical study marks a pivotal moment for clinical laboratories, signaling a potential paradigm shift in how…
Read More
A groundbreaking study conducted by researchers at Washington State University (WSU) has unveiled compelling evidence suggesting that even a singular…
Read More